The US Food and Drug Administration (FDA) has approved eye drops with 1.44% aceclidine, a world first for treating presbyopia, which affects most adults over 45. These drops contract the pupil, improving near vision without affecting distance vision. Clinical trials have shown that the effect appears within 30 minutes and lasts up to ten hours, with minimal side effects. The drug, called Vizz, will be available in the US from October 2025.
Sources
SUA aprobă primele picături pentru ochi care corectează vederea de aproape la adulți
Primele picături pentru ochi care corectează vederea de aproape, autorizate în SUA
Primele picături care corectează vederea de aproape. Soluția care te poate ajuta să renunți la ochelari la bătrânețe
Latest News
22:29
The U.S. Federal Reserve decided to maintain the benchmark interest rate at 3.75%-4%, despite persistent high inflation
22:14
Diana Stoica accuses PSD and AUR of blocking the Finance Minister’s hearing in Parliament
22:02
Cristela Georgescu accuses the proceedings in Călin Georgescu’s case of irregularities following the extension of his pretrial detention
21:54
Eurostat: Real per capita income rose by 0.1% in the EU in the second quarter of 2026, while the saving rate fell
21:26
MAE warns that transport services in Italy will be affected by a general strike on October 29 and 30
See more news